Stockreport

TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether The Sale Of Turning Point Therapeutics, Inc. Is Fair To Shareholders [TheStreet.com]

Turning Point Therapeutics, Inc. - Common stock  (TPTX) 
Last turning point therapeutics, inc. - common stock earnings: 3/16 09:00 am Check Earnings Report
PDF Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Turning Point Therapeutics, Inc. ( ) - to Bristol Myers Squibb for $76.00 per share i [Read more]